Insmed (INSM) Preferred Shares (2010)
Insmed (INSM) recorded quarterly Preferred Shares of $918000.0 in Q4 2010.
Insmed (INSM) Preferred Shares (2010) Analysis & Trends
Insmed's Preferred Shares history runs 1 years deep, the most recent figure standing at $918000.0 for Q4 2010.
- In Q4 2010, Preferred Shares changed N/A year-over-year to $918000.0; the TTM figure through Dec 2010 stood at $918000.0 (changed N/A YoY), while the FY2010 annual figure was $918000.0, changed N/A from the prior year.
- Preferred Shares was $918000.0 for Q4 2010 at Insmed.
- In the past five years, Preferred Shares ranged from a high of $918000.0 in Q4 2010 to a low of $918000.0 in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 918,000.00 |